Week 2 - L4 - Genetic Heterogeneity and the Complementation Test

Definition and Overview of Genetic Heterogeneity

  • Genetic heterogeneity is defined as a phenomenon where a single disease phenotype is caused by variants at different alleles (within the same gene) or at different loci (within different genes) across different families.

  • The central concept is that individuals may present with the same clinical phenotype but possess different underlying genotypes.

  • Heterogeneity is categorized into two primary types:

    • Allelic Heterogeneity: Many different variants within a single given gene or locus can be seen in different patients with a specific genetic condition.

    • Locus Heterogeneity: The same clinical phenotype results from variants at any one of several different loci (different genes) that lead to a disease.

  • Contrast with Pleiotropy:

    • Genetic heterogeneity is conceptually the opposite of pleiotropy.

    • In pleiotropy, one single gene affects multiple different phenotypes.

    • In genetic heterogeneity, multiple genes or different variants produce the same phenotype.

Locus Heterogeneity

  • Locus heterogeneity occurs when mutations at different genetic loci (different genes) result in the same clinical presentation.

  • This phenomenon may be due to epistasis, where the effect of one gene is dependent on the presence of one or more "modifier genes."

  • Examples of Locus Heterogeneity:

    • Albinism: A single clinical phenotype that can be caused by variants in four different genes.

    • Autosomal Dominant Polycystic Kidney Disease (ADPKD): This condition is caused by locus heterogeneity involving two distinct genes: PKD1PKD1 and PKD2PKD2. Despite the involvement of different genes, the resulting phenotype is the same: kidney and liver disease.

    • Deafness: It is estimated that variants in up to 152152 different genes can lead to deafness, demonstrating significant locus heterogeneity.

Allelic Heterogeneity

  • Allelic heterogeneity refers to different mutations or variants occurring within the same gene produced the same disease phenotype.

  • Case Study: Autosomal Recessive Polycystic Kidney Disease (ARPKD):

    • Commonly affects the PKHD1PKHD1 gene (distinguished from the PKD1PKD1 gene by the inclusion of "HH " in the name).

    • Patients have variants in the same gene, but the type of variant differs.

    • Variant types include:

      • Truncating variants.

      • Missense variants.

    • Despite these different variations within PKHD1PKHD1, the outward phenotype remains the same.

  • Case Study: Cystic Fibrosis:

    • This condition serves as a classic example of allelic heterogeneity where different variations in the same gene cause the same phenotype.

    • Common variants include:

      • 3-base pair deletion: This results in one missing amino acid, which causes the protein to fail to bind to the cell membrane.

      • Null variants: These results in no protein being produced at all.

      • Amino acid substitution: A single amino acid change that results in the protein functioning slowly.

    • Regardless of which of these specific variants an individual has, the clinical result is Cystic Fibrosis.

The Complementation Test

  • The complementation test is a method used to determine if a phenotype observed in two individuals is caused by variant alleles in the same gene or in different genes.

  • Procedure for Organisms:

    • If two organisms are homozygous for variants showing the same phenotype but the variants are in different genes, and they are crossed together:

      • The progeny will be wild type.

      • This indicates the variants complement one another because each parent provides the functional gene the other lacks.

    • If two organisms are homozygous for variants showing the same phenotype in the same gene, and they are crossed together:

      • The progeny will remain mutant (not wild type).

      • This indicates the variants fail to complement.

  • Genetic Example (Different Genes):

    • Individual 1 Genotype: AAbbAA bb (mutant phenotype due to gene BB).

    • Individual 2 Genotype: aaBBaa BB (mutant phenotype due to gene AA).

    • Cross (AAbb×aaBBAA bb \times aa BB) results in Progeny: AaBbAa Bb.

    • Because the progeny has at least one functional allele for both gene AA and gene BB, they produce functional protein products and exhibit the wild-type phenotype.

  • Genetic Example (Same Gene):

    • If both parents have a variant in gene AA, crossing them results in offspring who lack any functional version of gene AA protein, leading to the mutant phenotype.

  • Real-World Application: Deafness:

    • Scenario A: Two deaf individuals have children, and all offspring can hear. This confirms complementation; the parents had mutations in different genes (e.g., Parent 1 in gene AA, Parent 2 in gene BB).

    • Scenario B: Two deaf individuals have children, and all offspring are deaf. This indicates a failure to complement; both parents carry variants in the same gene.

    • Note: In pedigrees depicting these tests, a single line typically connects the parents (standard marriage/mating), even if it appears similar to the double lines used for consanguinity.

Integration of Concepts: BRCA1 and BRCA2

  • The variants in BRCA1BRCA1 and BRCA2BRCA2 genes illustrate the cumulative effects of various genetic expression variations:

    • Locus Heterogeneity: Two different genes (BRCA1BRCA1 and BRCA2BRCA2) can cause the same clinical risk/phenotype.

    • Allelic Heterogeneity: Within the BRCA1BRCA1 gene itself, many different specific variants can cause the phenotype.

    • Pleiotropy: Variants in these genes do not just cause one type of cancer; they are associated with a number of different cancers.

    • Age-Dependent Penetrance: While the variants are present from birth, the likelihood of developing cancer increases and is typically seen at later stages in life.